These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18700236)

  • 1. By the way, doctor. Should I get the cervical cancer vaccine?
    Gharib S
    Harv Health Lett; 2008 May; 33(7):3. PubMed ID: 18700236
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
    Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
    Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P; Cherry JD
    Pediatr Res; 2007 Nov; 62(5):527. PubMed ID: 18049369
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women.
    Charakorn C; Rattanasiri S; Lertkhachonsuk AA; Thanapprapasr D; Chittithaworn S; Wilailak S
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):160-7. PubMed ID: 21585696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-risk analysis of available cervix cancer vaccine: Situation analysis from Thailand.
    Wiwanitkit S; Wiwanitkit V
    J Cancer Res Ther; 2019; 15(6):1421. PubMed ID: 31898687
    [No Abstract]   [Full Text] [Related]  

  • 8. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do media reports and public brochures facilitate informed decision making about cervical cancer prevention?].
    Neumeyer-Gromen A; Bodemer N; Müller SM; Gigerenzer G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Nov; 54(11):1197-210. PubMed ID: 22015792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
    Lee FH; Paz-Soldan VA; Carcamo C; Garcia PJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):113-7. PubMed ID: 20354419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mandating a human papillomavirus vaccine: an investigation into whether such legislation is constitutional and prudent.
    Dowling TS
    Am J Law Med; 2008; 34(1):65-84. PubMed ID: 18512537
    [No Abstract]   [Full Text] [Related]  

  • 12. [Papillomavirus vaccines now allowed--ethical and logistical considerations].
    Höpfl R
    J Dtsch Dermatol Ges; 2007 May; 5(5):349-52. PubMed ID: 17451379
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV vaccine acceptability in Ghana, West Africa.
    Coleman MA; Levison J; Sangi-Haghpeykar H
    Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines and prevention of cervical cancer.
    Jansen KU; Shaw AR
    Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marketing and the HPV vaccine.
    Betensky M
    JAMA; 2009 Dec; 302(24):2660-1; author reply 2661. PubMed ID: 20040550
    [No Abstract]   [Full Text] [Related]  

  • 16. Lagging HPV vaccination rates dampen outlook in US: cloudy prospects for overcoming multiple barriers.
    Nelson B
    Cancer Cytopathol; 2010 Jun; 118(3):113-4. PubMed ID: 20544704
    [No Abstract]   [Full Text] [Related]  

  • 17. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
    Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
    Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gynecologic cancer--prevention strategy of cervical neoplasms with vaccine].
    Ochiai K
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):221. PubMed ID: 20235385
    [No Abstract]   [Full Text] [Related]  

  • 19. [HPV vaccine: making decisions in public health].
    Ciofi degli Atti ML; Donati S; Salmaso S
    Epidemiol Prev; 2007; 31(4):181-2. PubMed ID: 18019199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of cervical cancer by HPV vaccine].
    Konno R
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):236-9. PubMed ID: 20235395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.